Document:

Exhibit 10.2

  

March 5, 2021

 

NewHold Investment Corp.

950 McCarty Street, Building A

Houston, TX 77029

 

Re: Initial Public Offering

 

Ladies and Gentlemen:

 

This amended and restated letter (this
“Letter Agreement”) is being delivered to you (i) in accordance with the Underwriting Agreement (the
“Underwriting Agreement”), dated as of July 30, 2020, entered into by and among NewHold Investment Corp.,
a Delaware corporation (the “Company”), and Stifel, Nicolaus & Company, Incorporated, as representative
(the “Representative”) of the several underwriters (each, an “Underwriter”
and collectively, the “Underwriters”), relating to an underwritten initial public offering (the “Public
Offering”), of 17,250,000 of the Company’s units (including 2,250,000 units that were purchased to cover over-allotments)
(the “Units”), each comprised of one share of the Company’s Class A common stock, par value $0.0001
per share (the “Common Stock”), and one-half of one redeemable warrant and (ii) in connection with that
certain Agreement and Plan of Merger, dated as of the date hereof, by and among the Company, its wholly-owned subsidiary NHIC Sub
Inc., a Delaware corporation (“Merger Sub”) and Evolv Technologies, Inc., dba Evolv Technology,
Inc., a Delaware corporation (“Evolv”), pursuant to which, among other things, Merger Sub will
merger with and into Evolv, the separate corporate existence of Merger Sub would cease to exist and Evolv would continue as the
surviving corporation and become a wholly-owned subsidiary of the Company (the “Merger”). Each
whole warrant (each, a “Warrant”) entitles the holder thereof to purchase one share of Common Stock at
a price of $11.50 per share, subject to adjustment. The Units were sold in a Public Offering pursuant to a registration statement
on Form S-1 and prospectus (the “Prospectus”) filed by the Company with the U.S. Securities and Exchange
Commission (the “Commission”) and the Units were listed on The Nasdaq Capital Market. Certain capitalized
terms used herein are defined in paragraph 12 hereof.

 

In connection with the Public Offering
and the Merger, and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each of
NewHold Industrial Technology Holdings LLC (the “Sponsor”) and the undersigned individuals, each of whom
is a member of the Company’s board of directors and/or management team, or a holder of the Company’s Founder Shares
(each, an “Insider” and collectively, the “Insiders”), hereby agrees with the
Company as follows:

 

1. The Sponsor and
each Insider agrees that if the Company seeks stockholder approval of a proposed Business Combination, then in connection with
such proposed Business Combination, it, he or she shall (i) vote any shares of Capital Stock owned by it, him or her in favor of
any proposed Business Combination and (ii) not redeem any shares of Capital Stock owned by it, him or her in connection with such
stockholder approval. If the Company engages in a tender offer in connection with any proposed Business Combination, the Sponsor
and each Insider agrees that it, he or she will not seek to sell its, his or her shares of Capital Stock to the Company in connection
with such tender offer.

 

     

     

    

 

2. The Sponsor and
each Insider hereby agrees that in the event that the Company fails to consummate a Business Combination within 24 months from
the closing of the Public Offering, or such later period approved by the Company’s stockholders in accordance with the Company’s
amended and restated certificate of incorporation (the “Charter”), the Sponsor and each Insider shall
take all reasonable steps to cause the Company to (i) cease all operations except for the purpose of winding up, (ii) as promptly
as reasonably possible but not more than 10 Business Days thereafter, subject to lawfully available funds therefor, redeem 100%
of the Common Stock sold as part of the Units in the Public Offering (the “Offering Shares”), at a per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account (as defined below), including interest
earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes or to fund the Company’s
working capital requirements (as described in the Prospectus) (less up to $100,000 of interest to pay dissolution expenses), divided
by the number of then outstanding Offering Shares, which redemption will completely extinguish all Public Stockholders’ rights
as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders
and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under
Delaware law to provide for claims of creditors and other requirements of applicable law. The Sponsor and each Insider agrees not
to propose any amendment to the Charter to modify (i) the substance or timing of the ability of holders of Offering Shares to seek
redemption in connection with a Business Combination or the Company’s obligation to redeem 100% of the Offering Shares if
the Company does not complete a Business Combination by the date set forth in the Charter or (ii) the other provisions relating
to stockholders’ rights or pre-initial Business Combination activities, unless the Company provides Public Stockholders with
the opportunity to redeem their shares of Common Stock upon approval of any such amendment at a per-share price, payable in cash,
equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account
and not previously released to the Company to pay its taxes or to fund the Company’s working capital requirements (as described
in the Prospectus), divided by the number of then outstanding Offering Shares.

 

The Sponsor and each
Insider acknowledges that, with respect to the Founder Shares held by it, him or her, it, he or she has no right, title, interest
or claim of any kind in or to any monies held in the Trust Account as a result of any liquidation of the Company (although the
Sponsor, the Insiders and their respective affiliates shall be entitled to redemption and liquidation rights with respect to any
Offering Shares it or they hold if the Company fails to consummate a Business Combination within the time period set forth in the
Charter). The Sponsor and each Insider hereby further waives, with respect to any shares of Capital Stock held by it, him or her,
if any, any redemption rights it, he or she may have in connection with the consummation of a Business Combination, including,
without limitation, any such rights available in the context of a stockholder vote to approve such Business Combination or a stockholder
vote to approve an amendment to the Charter to (i) modify the substance or timing of the Company’s obligation to redeem 100%
of the Offering Shares if the Company has not consummated a Business Combination within the time period set forth in the Charter
or in the context of a tender offer made by the Company to purchase shares of Capital Stock or (ii) with respect to any other provision
relating to stockholders’ rights or pre-initial Business Combination activity.

 

3. During the period
commencing on the effective date of the Underwriting Agreement and ending 180 days after such date, the Sponsor and each Insider
shall not, without the prior written consent of the Representative, (i) sell, offer to sell, contract or agree to sell, hypothecate,
pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, any Units, shares
of Common Stock, Founder Shares, Warrants or any securities convertible into, or exercisable, or exchangeable for, shares of Common
Stock owned by it, him or her, (ii) establish or increase a put equivalent position or liquidate or decrease a call equivalent
position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
and the rules and regulations of the Commission promulgated thereunder, with respect to any Units, shares of Common Stock, Founder
Shares, Warrants or any securities convertible into, or exercisable, or exchangeable for, shares of Common Stock owned by it, him
or her, (iii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences
of ownership of any Units, shares of Common Stock, Founder Shares, Warrants or any securities convertible into, or exercisable,
or exchangeable for, shares of Common Stock owned by it, him or her, whether any such transaction is to be settled by delivery
of such securities, in cash or otherwise, or (iv) publicly announce any intention to effect any transaction specified in clause
(i), (ii) or (iii). Each of the Insiders and the Sponsor acknowledges and agrees that, prior to the effective date of any release
or waiver of the restrictions set forth in this paragraph 3 or paragraph 7 below, the Company shall announce the impending release
or waiver by press release through a major news service at least two Business Days before the effective date of the release or
waiver. Any release or waiver granted shall only be effective two Business Days after the publication date of such press release.
The provisions of this paragraph will not apply if the release or waiver is effected solely to permit a transfer not for consideration
and the transferee has agreed in writing to be bound by the same terms described in this Letter Agreement to the extent and for
the duration that such terms remain in effect at the time of the transfer.

 

    2

     

    

  

4. In the event of
the liquidation of the Trust Account upon the failure of the Company to consummate its initial Business Combination within the
time period set forth in the Charter, the Sponsor (the “Indemnitor”) agrees to indemnify and hold harmless
the Company against any and all loss, liability, claim, damage and expense whatsoever (including, but not limited to, any and all
legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, whether pending or
threatened) to which the Company may become subject as a result of any claim by (i) any third party for services rendered or products
sold to the Company or (ii) any prospective target business with which the Company has entered into a written letter of intent,
confidentiality or other similar agreement or Business Combination agreement (a “Target”); provided,
however, that such indemnification of the Company by the Indemnitor (x) shall apply only to the extent necessary to ensure that
such claims by a third party or a Target do not reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00
per Offering Share and (ii) the actual amount per Offering Share held in the Trust Account as of the date of the liquidation of
the Trust Account, if less than $10.00 per Offering Share is then held in the Trust Account due to reductions in the value of the
trust assets, less interest earned on the Trust Account which may be withdrawn to pay taxes, (y) shall not apply to any claims
by a third party or a Target which executed a waiver of any and all rights to the monies held in the Trust Account (whether or
not such waiver is enforceable) and (z) shall not apply to any claims under the Company’s indemnity of the Underwriters against
certain liabilities, including liabilities under the Securities Act of 1933, as amended. The Indemnitor shall have the right to
defend against any such claim with counsel of its choice reasonably satisfactory to the Company if, within 15 days following written
receipt of notice of the claim to the Indemnitor, the Indemnitor notifies the Company in writing that it shall undertake such defense.

 

5. Intentionally Omitted.

 

6. (a) The Sponsor
and the Insiders (other than Marc Saiontz, Neit Glat, Nick Petruska and Susan Quinn), hereby agree not to participate in the formation
of, or become an officer or director of, any special purpose acquisition company with a class of securities registered under the
Exchange Act, other than the Company, until the Company has entered into a definitive agreement regarding an initial Business Combination
or the Company has failed to complete an initial Business Combination within 24 months after the closing of the Public Offering,
as such period may be extended by Company stockholder approval. Marc Saiontz and Neit Glat hereby agree not to participate in the
formation of, or become an officer or director of, any industrial-focused special purpose acquisition company with a class of securities
registered under the Exchange Act, other than the Company, until the Company has entered into a definitive agreement regarding
an initial Business Combination or the Company has failed to complete an initial Business Combination within 24 months after the
closing of the Public Offering, as such period may be extended by Company stockholder approval.

 

(b) The Sponsor and
each Insider hereby agrees and acknowledges that: (i) the Underwriters and the Company would be irreparably injured in the event
of a breach by the Sponsor or an Insider of its, his or her obligations under paragraphs 1, 2, 3, 4, 6(a), 7(a), 7(b), and 9, as
applicable, of this Letter Agreement (ii) monetary damages may not be an adequate remedy for such breach and (iii) the non-breaching
party shall be entitled to injunctive relief, in addition to any other remedy that such party may have in law or in equity, in
the event of such breach.

 

    3

     

    

 

7.

(a)

 

(i) The Sponsor
and each Insider agrees that it, he or she shall not Transfer any Founder Shares (or shares of Common Stock issuable upon conversion
thereof) until the earlier of (A) one year after the completion of the Company’s initial Business Combination or (B) subsequent
to the Company’s initial Business Combination, (x) if the last reported sale price of the Common Stock equals or exceeds
$12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading
days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (y)
the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction
that results in all of the Company’s stockholders having the right to exchange their shares of Common Stock for cash, securities
or other property (the “Founder Shares Lock-up Period”).

 

(ii) In addition,
the following provisions shall apply with respect to the Founders Shares:

 

(A)       1,897,500
shares of the Company’s Class B common stock shall vest and no longer be subject to forfeiture at the closing of a Business
Combination;

 

(B)       if
within 5-years after the signing date of the Business Combination the last reported sale price of the Common Stock equals or exceeds
$12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading
days within any 30-trading day period, then 948,750 shares of the Company’s Class B common stock shall vest and no longer
be subject to forfeiture;

 

(C)       if
within 5-years after the signing date of the Business Combination the last reported sale price of the Common Stock equals or exceeds
$15.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading
days within any 30-trading day period, then 948,750 shares of the Company’s Class B common stock) shall vest and no longer
be subject to forfeiture;

 

(D)       if
the conditions specified in clause (B) and/or (C) above are not satisfied, then the number of shares specified in clause (B) and/or
(C), as the case may be, shall be forfeited and no longer issued and outstanding; and

 

(E)       if,
within 5-years after the signing date of a Business Combination, there is a Change of Control (as hereinafter defined), then immediately
prior to the consummation of such Change of Control, then all of the Founder Shares referred to in clauses (B) and (C) above shall
vest, no longer be subject to forfeiture and shall be eligible to participate in such Change of Control. “Change of Control”
means any transaction or series of transactions the result of which is: (a) the acquisition by any Person or group (as defined
under Section 13 of the Exchange Act) of Persons of direct or indirect beneficial ownership of securities representing 50% or more
of the combined voting power of the then outstanding securities of Parent; (b) a merger, consolidation, business combination, recapitalization,
reorganization, or other similar transaction, however effected, resulting in any Person or group (as defined under Section 13 of
the Exchange Act) acquiring 50% or more of the combined voting power of the then outstanding securities of Company or the surviving
or successor entity immediately after such combination; (c) a sale of all or substantially all of the assets of Company and its
Subsidiaries (as hereinafter defined), taken as a whole; provided, however, that any securities of Parent issued
in a bona fide financing transaction or series of bona fide financing transactions shall be excluded from the definition of “Change
of Control”. “Subsidiaries” means, with respect to any Person, any other Person of which at least a majority
of the securities or ownership interests having by their terms ordinary voting power to elect a majority of the board of directors
or other persons performing similar functions is directly or indirectly owned or controlled by such Person or by one or more of
its Subsidiaries.

 

    4

     

    

 

(b) The Sponsor and
each Insider agrees that, to the extent it, he or she holds Private Placement Warrants, it, he or she shall not Transfer any Private
Placement Warrants (or shares of Common Stock underlying such Private Placement Warrants), until 30 days after the Company’s
completion of its initial Business Combination (the “Private Placement Warrants Lock-up Period”, together
with the Founder Shares Lock-up Period, the “Lock-up Periods”).

 

(c) Notwithstanding
the provisions set forth in paragraphs 7(a) and (b), Transfers of the Founder Shares, the Private Placement Warrants and the shares
of Common Stock issued or issuable upon the exercise or conversion of the Private Placement Warrants or the Founder Shares and
that are held by the Sponsor, any Insider or any of their permitted transferees (that have complied with this paragraph 7(c)),
are permitted (a) to the Company’s officers or directors, any affiliate or family member of any of the Company’s officers
or directors, any affiliate of the Sponsor or any member of the Sponsor; (b) in the case of an individual, by gift to a member
of such individual’s immediate family or to a trust, the beneficiary of which is a member of such individual’s immediate
family, an affiliate of such individual or to a charitable organization; (c) in the case of an individual, by virtue of laws of
descent and distribution upon death of such individual; (d) in the case of an individual, pursuant to a qualified domestic relations
order; (e) by private sales or transfers made in connection with the consummation of the Company’s initial Business Combination
at prices no greater than the price at which the Founder Shares, shares of Common Stock or Private Placement Warrants were originally
purchased; (f) in the event of the Company’s liquidation prior to the completion of an initial Business Combination; or (g)
by virtue of the laws of the State of Delaware or the Sponsor’s limited liability company agreement upon dissolution of the
Sponsor; provided, however, that in the case of clauses (a) through (e) or (g), any such permitted transferees must enter into
a written agreement with the Company agreeing to be bound by the transfer restrictions in this paragraph 7(c) and the other restrictions
contained in this Letter Agreement.

 

8. The Sponsor and
each Insider represents and warrants that it, he or she has never been suspended or expelled from membership in any securities
or commodities exchange or association or had a securities or commodities license or registration denied, suspended or revoked.
Each Insider’s biographical information furnished to the Company (including any such information included in the Prospectus)
is true and accurate in all respects and does not omit any material information with respect to the Insider’s background.
Each Insider’s questionnaire furnished to the Company is true and accurate in all respects. Each Insider represents and warrants
that: it, he or she is not subject to or a respondent in any legal action for, any injunction, cease-and-desist order or order
or stipulation to desist or refrain from any act or practice relating to the offering of securities in any jurisdiction; it, he
or she has never been convicted of, or pleaded guilty to, any crime (i) involving fraud, (ii) relating to any financial transaction
or handling of funds of another person, or (iii) pertaining to any dealings in any securities and it, he or she is not currently
a defendant in any such criminal proceeding.

 

9. Except as disclosed
in the Prospectus, neither the Sponsor nor any officer, nor any affiliate of the Sponsor or any officer, nor any director of the
Company, shall receive from the Company any finder’s fee, reimbursement, consulting fee, monies in respect of any repayment
of a loan or other compensation prior to, or in connection with any services rendered in order to effectuate, the consummation
of the Company’s initial Business Combination (regardless of the type of transaction that it is), other than the following,
none of which will be made from the proceeds held in the Trust Account prior to the completion of the initial Business Combination:
repayment of a loan and advances up to an aggregate of $300,000 made to the Company by the Sponsor; payment to an affiliate of
the Sponsor for certain office space, utilities and secretarial and administrative support as may be reasonably required by the
Company for a total of $15,000 per month; reimbursement for any reasonable out-of-pocket expenses related to identifying, investigating
and consummating an initial Business Combination; and repayment of loans, if any, and on such terms as to be determined by the
Company from time to time, made by the Sponsor or an affiliate of the Sponsor or any of the Company’s officers or directors
to finance transaction costs in connection with an intended initial Business Combination, provided, that, if the Company does not
consummate an initial Business Combination, a portion of the working capital held outside the Trust Account may be used by the
Company to repay such loaned amounts so long as no proceeds from the Trust Account are used for such repayment. Up to $100,000
of such loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender. Such warrants would
be identical to the Private Placement Warrants, including as to exercise price, exercisability and exercise period.

 

    5

     

    

 

11. The Sponsor and
each Insider has full right and power, without violating any agreement to which it is bound (including, without limitation, any
non-competition or non-solicitation agreement with any employer or former employer), to enter into this Letter Agreement and, as
applicable, to serve as an officer or director of the Company and hereby consents to being named in the Prospectus as an officer
or director of the Company.

 

12. As used herein,
(i) “Anchor Investors” shall mean certain funds and accounts managed by Magnetar Financial LLC, UBS O’Connor
LLC and Mint Tower Capital Management B.V., that have expressed to the Company an interest to purchase a portion of an aggregate
of $40,000,000 of Units in the Public Offering; (ii) “Business Combination” shall mean a merger, capital
stock exchange, asset acquisition, stock purchase, reorganization or similar business combination, involving the Company and one
or more businesses; (iii) “Business Day” means each day that is not a Saturday, Sunday or other day on
which banking institutions in The City of New York, New York, are authorized or required by law to close; (iv) “Capital
Stock” shall mean, collectively, the Common Stock and the Founder Shares; (v) “Founder Shares”
shall mean the 4,312,500 shares of the Company’s Class B common stock, par value $0.0001 per share, (up to 562,500 Shares
of which are subject to complete or partial forfeiture by the Sponsor and the Anchor Investors, collectively, if the over-allotment
option is not exercised by the Underwriters) outstanding immediately prior to the consummation of the Public Offering; (vi) “Initial
Stockholders” shall mean the Sponsor, the Anchor Investors and any Insider that holds Founder Shares prior to the
consummation of the Public Offering; (vii) “Private Placement Warrants” shall the Warrants to purchase
up to 5,250,000 shares of Common Stock (or 5,700,000 shares of Common Stock if the over-allotment option is exercised in full by
the Underwriters) that the Sponsor and the Anchor Investors have agreed to purchase for an aggregate purchase price of $5,250,000
(or $5,700,000 if the over-allotment option is exercised in full by the Underwriters), or $1.00 per Warrant, in a private placement
that shall occur simultaneously with the consummation of the Public Offering; (viii) “Public Stockholders”
shall mean the holders of the Offering Shares; (ix) “Trust Account” shall mean the trust fund into which
a portion of the net proceeds of the Public Offering and the sale of Private Placement Warrants shall be deposited; and (x) “Transfer”
shall mean the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase
or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position
or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange Act,
and the rules and regulations of the Commission promulgated thereunder with respect to, any security, (b) entry into any swap or
other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security,
whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) public announcement
of any intention to effect any transaction specified in clause (a) or (b).

 

    6

     

    

 

13. The Company will
maintain an insurance policy or policies providing directors’ and officers’ liability insurance, and each Director
shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage available
for any of the Company’s directors or officers.

 

14. This Letter Agreement
constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter hereof and supersedes
all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate
in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement may not be changed, amended,
modified or waived (other than to correct a typographical error) as to any particular provision, except by a written instrument
executed by all parties hereto.

 

15. No party hereto
may assign either this Letter Agreement or any of its rights, interests, or obligations hereunder without the prior written consent
of the other parties. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate
to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding on the Sponsor and
each Insider and their respective successors, heirs and assigns and permitted transferees.

 

16. Nothing in this
Letter Agreement shall be construed to confer upon, or give to, any person or corporation other than the parties hereto any right,
remedy or claim under or by reason of this Letter Agreement or of any covenant, condition, stipulation, promise or agreement hereof.
All covenants, conditions, stipulations, promises and agreements contained in this Letter Agreement shall be for the sole and exclusive
benefit of the parties hereto and their successors, heirs, personal representatives and assigns and permitted transferees.

 

17. This Letter Agreement
may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes be deemed
to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

18. This Letter Agreement
shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity
or enforceability of this Letter Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or
unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Letter Agreement a provision
as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

19. This Letter Agreement
shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving effect to
conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The parties hereto
(i) all agree that any action, proceeding, claim or dispute arising out of, or relating in any way to, this Letter Agreement shall
be brought and enforced in the courts of New York City, in the State of New York, and irrevocably submit to such jurisdiction and
venue, which jurisdiction and venue shall be exclusive and (ii) waive any objection to such exclusive jurisdiction and venue or
that such courts represent an inconvenient forum.

 

20. Any notice, consent
or request to be given in connection with any of the terms or provisions of this Letter Agreement shall be in writing and shall
be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or facsimile
transmission.

 

21. This Letter Agreement
shall terminate on the earlier of (i) the expiration of the Lock-up Periods or (ii) the liquidation of the Company; provided, however,
that this Letter Agreement shall earlier terminate in the event that the Public Offering is not consummated by August 31, 2020;
provided further that paragraph 4 of this Letter Agreement shall survive such liquidation. Notwithstanding the foregoing, the provisions
of paragraph 7(a) (ii) of this Letter Agreement shall survive for a period of 5 years after the signing date of the Business Combination.

 

[Signature Page Follows]

 

    7

     

    

     

	 	Sincerely,  
	 	 	 	 
	 	NEWHOLD INDUSTRIAL TECHNOLOGY HOLDINGS LLC
	 	 	 	 
	 	By:	/s/ Kevin Charlton

	 	 	Name:	Kevin Charlton
	 	 	Title:  	Manager
	 	 	 	 
	 	By:	/s/ Marc Saiontz

	 	 	Name:	Marc Saiontz
	 	 	Title:  	Manager
	 	 	 	 
	 	By:	/s/ Charles Goldman

	 	 	Name: 	Charles Goldman
	 	 	Title:	Manager
	 	 	 	 
	 	 	/s/ Kevin Charlton

	 	 	Kevin Charlton
	 	 	 
	 	 	/s/ Thomas J. Sullivan

	 	 	Thomas J. Sullivan
	 	 	 
	 	 	/s/ Charles Goldman

	 	 	Charles Goldman
	 	 	 
	 	 	/s/ John Charles Baynes-Reid

	 	 	John Charles Baynes-Reid
	 	 	 
	 	 	/s/ Adam Deutsch

	 	 	Adam Deutsch
	 	 	 
	 	 	/s/ Marc Saiontz

	 	 	Marc Saiontz
	 	 	 
	 	 	/s/ Kathleen Harris

	 	 	Kathleen Harris 
	 	 	 
	 	 	/s/ Brian Mathis

	 	 	Brian Mathis
	 	 	 
	 	 	/s/ Neil Glat

	 	 	Neil Glat 
	 	 	 
	 	 	/s/ Sezaneh Taharian

	 	 	Sezaneh Taharian
	 	 	 
	 	 	/s/ Nicholas Petruska

	 	 	Nicholas Petruska
	 	 	 
	 	 	/s/ Susan Quinn

	 	 	Susan Quinn
	 	 	 
	 	Acknowledged and Agreed:
	 	 	 	 
	 	NEWHOLD INVESTMENT CORP.
	 	 
	 	By:	/s/ Kevin Charlton

	 	 	Name:	Kevin Charlton
	 	 	Title:  	Chief Executive Officer

 

[Signature page to Amended and Restated
Insider Letter]

 

     

     

    

     

	 	Acknowledged and Agreed:
	 	 	 
	 	EVOLV TECHNOLOGIES, INC.
	 	 	
         

	 	By:	/s/ Peter George

	 	 	Name: 	 Peter George
	 	 	Title:  	Chief Executive Officer

 

[Signature page to
Amended and Restated Insider Letter]Exhibit 10.3

 

FORM OF SUBSCRIPTION AGREEMENT

 

This SUBSCRIPTION AGREEMENT
(this “Subscription Agreement”) is entered into this ___ day of March, 2021, by and between NewHold Investment
Corp., a Delaware corporation (the “Company”), and the undersigned (“Subscriber” or “you”).
Defined terms used but not otherwise defined herein shall have the respective meanings ascribed thereto in the Transaction Agreement
(as defined below).

 

WHEREAS, the Company
and the other parties named therein propose to enter into a Merger Agreement substantially in the form provided to Subscriber (the
“Transaction Agreement”), pursuant to which, among other things, a wholly-owned subsidiary of the Company will
merge with and into Evolv Technologies, Inc., a Delaware corporation (together with its subsidiaries, “Evolv”),
pursuant to which Evolv will continue as the surviving corporation and as a wholly-owned subsidiary of the Company (the “Transaction”);

 

WHEREAS, in connection
with the Transaction, Subscriber desires to subscribe for and purchase from the Company that number of the Company’s Class
A common stock, par value $0.0001 per share (the “Common Stock”), set forth on the signature page hereto for
a purchase price of $10.00 per share (the “Per Share Price”), or the aggregate purchase price set forth on the
signature page hereto (the “Purchase Price”), and the Company desires to issue and sell to Subscriber the Securities
in consideration of the payment of the Purchase Price by or on behalf of Subscriber to the Company on or prior to the Closing (as
defined below); and

 

WHEREAS, in connection
with the Transaction, certain other institutional “accredited investors” (within the meaning of Rule 501(a) under the
Securities Act of 1933, as amended (the “Securities Act”)) or “qualified institutional buyers” (within
the meaning of Rule 144A under the Securities Act) (the “Other Subscribers”) have entered into separate subscription
agreements with the Company (“Other Subscription Agreements”) substantially similar to this Subscription Agreement,
pursuant to which such investors have, together with the Subscriber pursuant to this Subscription Agreement, agreed to purchase
an aggregate of up to 30,000,000 shares of Common Stock at the Per Share Price.

 

NOW, THEREFORE, in
consideration of the foregoing and the mutual representations, warranties and covenants, and pursuant to the terms and subject
to the conditions, herein contained, and intending to be legally bound hereby, the parties hereto hereby agree as follows:

 

1. Subscription.
Subject to the terms and conditions hereof, Subscriber hereby agrees to subscribe for and purchase from the Company, on or prior
to the Closing, and the Company hereby agrees to issue and sell to Subscriber, on or prior to the Closing, upon the payment of
the Purchase Price, _______________ shares of the Common Stock (the “Securities”) on the terms and conditions
set forth herein (such subscription and issuance, the “Subscription”).

 

     

     

    

 

2. Representations,
Warranties and Agreements.

 

2.1 Subscriber’s
Representations, Warranties and Agreements. To induce the Company to issue the Securities to Subscriber, Subscriber hereby
represents and warrants to the Company and agrees with the Company as follows:

 

2.1.1 If
Subscriber is not an individual, Subscriber has been duly formed or incorporated and is validly existing in good standing under
the laws of its jurisdiction of incorporation or formation, with power and authority to enter into, deliver and perform its obligations
under this Subscription Agreement. If Subscriber is an individual, Subscriber has the authority to enter into, deliver and perform
its obligations under this Subscription Agreement.

 

2.1.2 If
Subscriber is not an individual, this Subscription Agreement has been duly authorized, executed and delivered by Subscriber. If
Subscriber is an individual, the signature on this Subscription Agreement is genuine, and Subscriber has legal competence and capacity
to execute the same. Assuming that this Subscription Agreement constitutes the valid and binding agreement of the Company, this
Subscription Agreement is a valid and binding obligation of Subscriber, enforceable against Subscriber in accordance with its terms,
except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium
or other laws relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered
at law or equity.

 

2.1.3 The
execution, delivery and performance by Subscriber of this Subscription Agreement and the consummation of the transactions contemplated
herein do not and will not (i) result in a breach or violation of any of the terms or provisions of, or constitute a default
under the terms of any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which
Subscriber is a party or by which Subscriber is bound or to which any of the property or assets of Subscriber is subject, which
would reasonably be expected to have a material adverse effect on the business, properties, financial condition, stockholders’
equity or results of operations of Subscriber and its subsidiaries, taken as a whole (a “Subscriber Material Adverse Effect”),
or materially affect the legal authority of Subscriber to comply in all material respects with the terms of this Subscription Agreement;
(ii) if Subscriber is not an individual, result in any violation of the provisions of the organizational documents of Subscriber
or any of its subsidiaries; or (iii) result in any violation of any statute or any judgment, order, rule or regulation of
any court or government or governmental, tribunal, judicial, administrative federal, state, local, or foreign or any agency, bureau,
board, commission instrumentality or authority thereof, including any state’s attorney general or any court or arbitrator
(public or private) (“Authority”), having jurisdiction over Subscriber or any of its subsidiaries or any of
their respective properties that would reasonably be expected to have a Subscriber Material Adverse Effect.

 

    2

     

    

 

2.1.4 Subscriber
(i) is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or an institutional
“accredited investor” (within the meaning of Rule 501(a) under the Securities Act) satisfying the applicable requirements
set forth on Schedule A, (ii) is acquiring the Securities only for its own account and not for the account of others,
or if Subscriber is subscribing for the Securities as a fiduciary or agent for one or more investor accounts, each owner of such
account is a “qualified institutional buyer” or an “accredited investor” and Subscriber has full investment
discretion with respect to each such account, and the full power and authority to make the acknowledgements, representations, warranties
and agreements herein on behalf of each owner of each such account, and (iii) is not acquiring the Securities with a view
to, or for offer or sale in connection with, any distribution thereof in violation of the Securities Act (and shall provide the
requested information on Schedule A following the signature page hereto). Subscriber is not an entity formed for the specific
purpose of acquiring the Securities unless such entity is an accredited investor within the meaning of Rule 501(a)(8) under the
Securities Act and all of the equity owners in such entity are accredited investors. Subscriber understands and acknowledges that
the purchase of the Securities pursuant to this Agreement is intended the exemptions from filing under FINRA Rule 5123(b)(1)(A)(C)
or (J).

 

2.1.5 Subscriber
understands that the Securities are being offered in a transaction not involving any public offering within the meaning of the
Securities Act and that the Securities have not been registered under the Securities Act. Subscriber understands that the Securities
may not be resold, transferred, pledged or otherwise disposed of by Subscriber absent an effective registration statement under
the Securities Act with respect to the Securities except (i) to the Company or a subsidiary thereof, or (ii) pursuant to another
applicable exemption from the registration requirements of the Securities Act that is available and that any certificates or book
entries representing the Securities shall contain a legend to such effect. Subscriber understands and agrees that the Securities
will be subject to the foregoing transfer restrictions and, as a result of these transfer restrictions, Subscriber may not be able
to readily resell the Securities and may be required to bear the financial risk of an investment in the Securities for an indefinite
period of time. Subscriber understands that it has been advised to consult legal counsel prior to making any offer, resale, pledge
or transfer of any of the Securities.

 

2.1.6 Subscriber
understands and agrees that Subscriber is purchasing the Securities directly from the Company. Subscriber further acknowledges
that there have been no representations, warranties, covenants and agreements made to Subscriber by the Company or any of its officers
or directors, expressly or by implication, other than those representations, warranties, covenants and agreements included in this
Subscription Agreement, and Subscriber is not relying on any representations, warranties or covenants other than those expressly
set forth in this Subscription Agreement.

 

2.1.7 Subscriber
represents and warrants that (i) it is not a Benefit Plan Investor as contemplated by the Employee Retirement Income Security
Act of 1974, as amended, or (ii) its acquisition and holding of the Securities will not constitute or result in a non-exempt
prohibited transaction under Section 406 of the Employee Retirement Income Security Act of 1974, as amended, Section 4975
of the Internal Revenue Code of 1986, as amended (the “Code”), or any applicable similar law.

 

    3

     

    

 

2.1.8 In
making its decision to purchase the Securities, Subscriber represents that it has relied solely upon independent investigation
made by Subscriber and the representations, warranties, and covenants of the Company contained in this Subscription Agreement.
The Subscriber acknowledges and agrees that the Subscriber has received and has had an adequate opportunity to review, such financial
and other information as the Subscriber deems necessary in order to make an investment decision with respect to the Securities
and made its own assessment and is satisfied concerning the relevant tax and other economic considerations relevant to the Subscriber’s
investment in the Securities. Without limiting the generality of the foregoing, the Subscriber acknowledges that it has reviewed
the documents provided to the Subscriber by the Company. The Subscriber represents and agrees that the Subscriber has had the full
opportunity to ask such questions, receive such answers and obtain such information as the Subscriber has deemed necessary to make
an investment decision with respect to the Securities. The Subscriber acknowledges that (i) it has not relied on any statements
or other information provided by Cowen and Company, LLC (the “Placement Agents” or any of the Placement Agents’
affiliates with respect to its decision to invest in the Securities, including information related to the Company, the Securities
and the offer and sale of the Securities and (ii) the information provided to the Subscriber is preliminary and subject to change.

  

2.1.9 Subscriber
became aware of this offering of the Securities solely (a) by means of direct contact from the Placement Agents, the Company, Evolv
or a representative of the Company or Evolv, or (b) directly from the Company as a result of a pre-existing, substantial relationship
with the Company, and the Securities were offered to Subscriber solely by direct contact between Subscriber and any of the Placement
Agents or the Company. Subscriber did not become aware of this offering of the Securities, nor were the Securities offered to Subscriber,
by any other means. Subscriber acknowledges that the Placement Agents have not acted as its financial advisor or fiduciary. Subscriber
acknowledges that the Company represents and warrants that the Securities (i) were not offered by any form of general solicitation
or general advertising and (ii) are not being offered in a manner involving a public offering under, or in a distribution
in violation of, the Securities Act, or any state securities laws.

 

2.1.10 Subscriber
acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Securities. Subscriber
has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment
in the Securities, and Subscriber has sought such accounting, legal and tax advice as Subscriber has considered necessary to make
an informed investment decision. Subscriber understands and acknowledges that (A) it (i) is a sophisticated investor and capable
of evaluating investment risks independently and (ii) has exercised independent judgment in evaluating our participation in the
purchase of the Securities and (B) the purchase and sale of the Securities hereunder meets (i) the exemptions from filing under
FINRA Rule 5123(b)(1)(A) and (ii) the institutional customer exemption under FINRA Rule 2111(b).

 

2.1.11 Subscriber
represents and acknowledges that Subscriber has such knowledge and experience in financial and business matters as to be capable
of evaluating the merits and risks of the investment in the Securities, has analyzed and fully considered the risks of an investment
in the Securities and determined that the Securities are a suitable investment for Subscriber and that Subscriber is able at this
time and in the foreseeable future to bear the economic risk of a total loss of Subscriber’s investment in the Company. Subscriber
further acknowledges specifically that a possibility of total loss of investment exists.

 

    4

     

    

 

2.1.12 Subscriber
understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Securities
or made any findings or determination as to the fairness of this investment.

 

2.1.13 Subscriber
represents and warrants that Subscriber is not (i) a person or entity named on the List of Specially Designated Nationals
and Blocked Persons, the Executive Order 13599 List, the Foreign Sanctions Evaders List, or the Sectoral Sanctions Identification
List, each of which is administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”)
or in any Executive Order issued by the President of the United States and administered by OFAC (“OFAC List”),
or a person or entity prohibited by any OFAC sanctions program, (ii) owned or controlled by, or acting on behalf of, a person,
that is named on an OFAC List; (iii) organized, incorporated, established, located, resident or born in, or a citizen, national,
or the government, including any political subdivision, agency, or instrumentality thereof, of any country or territory embargoed
or subject to substantial trade restrictions by the United States; (iv) a Designated National as defined in the Cuban Assets
Control Regulations, 31 C.F.R. Part 515, or (v) a non-U.S. shell bank or providing banking services indirectly to a non-U.S.
shell bank (collectively, a “Prohibited  Investor”). Subscriber agrees to provide law enforcement
agencies, if requested thereby, such records as required by applicable law, provided that Subscriber is permitted to do so under
applicable law. Subscriber represents that if it is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311
et seq.) (the “BSA”), as amended by the USA PATRIOT Act of 2001 (the “PATRIOT Act”), and
its implementing regulations (collectively, the “BSA/PATRIOT Act”), that Subscriber, directly or indirectly
through a third party administrator, maintains policies and procedures reasonably designed to comply with applicable obligations
under the BSA/PATRIOT Act. Subscriber also represents that, to the extent required, it, directly or indirectly through a third
party administrator, maintains policies and procedures reasonably designed for the screening of its investors against the OFAC
sanctions programs, including the OFAC List, and to otherwise ensure compliance with OFAC-administered sanctions programs. Subscriber
further represents and warrants that, to the extent required, it, directly or indirectly, through a third party administrator,
maintains policies and procedures reasonably designed to ensure that the funds held by Subscriber and used to purchase the Securities
were legally derived.

 

2.1.14 On
the date the Purchase Price will be required to be funded to the Company pursuant to Section 3.1, Subscriber will have sufficient
funds to pay the Purchase Price.

 

2.1.15 Subscriber
represents that no disqualifying event described in Rule 506(d)(1)(i)-(viii) under the Securities Act (a “Disqualification
Event”) is applicable to Subscriber or any of its Rule 506(d) Related Parties (as defined below), except, if applicable,
for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable. Subscriber hereby agrees that it
shall notify the Company promptly in writing in the event a Disqualification Event becomes applicable to Subscriber or any of its
Rule 506(d) Related Parties, except, if applicable, for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3)
is applicable. For purposes of this Section 2.1.15, “Rule 506(d) Related Party” shall mean a person or entity that
is a direct beneficial owner of Subscriber’s securities for purposes of Rule 506(d) under the Securities Act.

 

    5

     

    

 

2.1.16 No
broker, finder or other financial consultant has acted on behalf of Subscriber in connection with this Subscription Agreement or
the transactions contemplated hereby in such a way as to create any liability on the Company.

 

2.1.17 Except
as expressly disclosed in a Schedule 13D or Schedule 13G (or amendments thereto) filed by such Subscriber with the Commission with
respect to the beneficial ownership of the Company’s Common Stock prior to the date hereof, Subscriber is not currently (and
at all times through Closing will refrain from being or becoming) a member of a “group” (within the meaning of Section
13(d)(3) or Section 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or any successor
provision) acting for the purpose of acquiring, holding or disposing of equity securities of the Company (within the meaning of
Rule 13d-5(b)(1) under the Exchange Act).

 

2.1.18 No
foreign person (as defined in 31 C.F.R. Part 800.224) in which the national or subnational governments of a single foreign state
have a substantial interest (as defined in 31 C.F.R. Part 800.244) will acquire a substantial interest in the Company as a result
of the purchase and sale of Securities hereunder such that a declaration to the Committee on Foreign Investment in the United States
would be mandatory under 31 C.F.R. Part 800.401, and no foreign person will have control (as defined in 31 C.F.R. Part 800.208)
over the Company from and after the Closing as a result of the purchase and sale of Securities hereunder

 

2.2 Company’s
Representations, Warranties and Agreements. To induce Subscriber to purchase the Securities, the Company hereby represents
and warrants to Subscriber and agrees with Subscriber as follows:

 

2.2.1 The
Company has been duly incorporated and is validly existing as a corporation in good standing under the Delaware General Corporation
Law (the “DGCL”), with corporate power and authority to own, lease and operate its properties and conduct its
business as presently conducted and to enter into, deliver and perform its obligations under this Subscription Agreement.

 

2.2.2 The
Securities have been duly authorized and, when issued and delivered to Subscriber against full payment for the Securities in accordance
with the terms of this Subscription Agreement, and registered with the Company’s transfer agent, the Securities will be validly
issued, fully paid, non-assessable and free and clear of any liens or other restrictions whatsoever (other than those arising under
state or federal securities laws or as set forth herein) the Securities have not have been authorized, and will not be issued in
violation of or subject to any preemptive or similar rights created under the Company’s amended and restated certificate
of incorporation or bylaws or under the DGCL or any agreement to which the Company is a party.

 

2.2.3 Each
of this Subscription Agreement, the Other Subscription Agreements and the Transaction Agreement (the “Transaction Documents”)
has been duly authorized, executed and delivered by the Company and is a valid and binding obligation of the Company, enforceable
against it in accordance with its terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles
of equity, whether considered at law or equity.

 

    6

     

    

 

2.2.4 The
execution, delivery and performance of this Subscription Agreement and the other Transaction Documents (including compliance by
the Company with all of the provisions hereof and thereof), the issuance and sale of the Securities and the consummation of the
certain other transactions contemplated herein and therein will not (i) conflict with or result in a breach or violation of any
of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance
upon any of the property or assets of the Company pursuant to the terms of any indenture, mortgage, deed of trust, loan agreement,
lease, license or other agreement or instrument to which the Company is a party or by which the Company is bound or to which any
of the property or assets of the Company is subject, which would, individually or in the aggregate, reasonably be expected to have
a material adverse effect on the business, properties, assets, liabilities, operations, financial condition, stockholders’
equity or results of operations of the Company (a “Material Adverse Effect”) or materially affect the validity
of the Securities or the legal authority of the Company to comply in all material respects with the terms of this Subscription
Agreement; (ii) result in any violation of the provisions of the organizational documents of the Company; or (iii) result
in any violation of any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic
or foreign, having jurisdiction over the Company or any of its properties that would reasonably be expected to have a Material
Adverse Effect or materially affect the validity of the Securities or the legal authority of the Company to comply in all material
respects with this Subscription Agreement.

 

2.2.5 Neither
the Company, nor any person acting on its or their behalf has, directly or indirectly, made any offers or sales of any Company
security or solicited any offers to buy any security, under circumstances that would adversely affect reliance by the Company on
Section 4(a)(2) of the Securities Act for the exemption from registration for the transactions contemplated hereby or would
require registration of the issuance or sale of the Securities under the Securities Act.

 

2.2.6 Neither
the Company nor any person acting on its behalf has conducted any general solicitation or general advertising (as those terms are
used in Regulation D under the Securities Act) in connection with the offer or sale of any of the Securities and neither the Company,
nor any person acting on its behalf has offered any of the Securities in a manner involving any public offering under, or in a
distribution in violation of, the Securities Act or any state securities laws.

 

2.2.7 Immediately
after the Closing, Evolv will be a wholly owned subsidiary of the Company and, except as described in the Transaction Agreement,
there will be no outstanding options, warrants or other rights to subscribe for, purchase or acquire from Evolv or any of its subsidiaries
any equity interests in Evolv or any of its subsidiaries, or securities convertible into or exchangeable or exercisable for such
equity interests.

 

    7

     

    

 

2.2.8 The
Company has not taken any steps to seek protection pursuant to any law or statute relating to bankruptcy, insolvency, reorganization,
receivership, liquidation, administration or winding up or failed to pay its debts when due, nor does the Company have any knowledge
or reason to believe that any of their respective creditors intend to initiate involuntary bankruptcy proceedings or seek to commence
an administration.

 

2.2.9 No
Disqualification Event is applicable to the Company or, to the Company’s knowledge, any Company Covered Person (as defined
below), except for a Disqualification Event as to which Rule 506(d)(2)(ii)-(iv) or (d)(3) under the Securities Act is applicable.
The Company has complied, to the extent applicable, with any disclosure obligations under Rule 506(e) under the Securities Act.
“Company Covered Person” means, with respect to the Company as an “issuer” for purposes of Rule
506 under the Securities Act, any person listed in the first paragraph of Rule 506(d)(1) under the Securities Act.

 

2.2.10 As
of the date of this Subscription Agreement, the authorized capital stock of the Company consists of 45,000,000 shares of Class
A common stock, par value $0.0001 per share, 5,000,000 shares of Class B common stock, par value $0.0001 per share and 1,000,000
shares of preferred shares, par value $0.0001 per share, of which 17,250,000 shares of Class A common stock of the Company and
4,312,500 shares of Class B common stock of the Company are issued and outstanding as of the date hereof and no preferred shares
are issued and outstanding. 16,312,768 shares of Common Stock are reserved for issuance upon the exercise of warrants (“Option
Rights”). All (i) issued and outstanding shares of Common Stock have been duly authorized and validly issued, are fully
paid and are non-assessable and are not subject to preemptive rights and (ii) outstanding Option Rights have been duly authorized
and validly issued, are fully paid and are not subject to preemptive rights. As of the date hereof, except as set forth above pursuant
to the organizational documents of the Company, the Other Subscription Agreements, the Transaction Agreement and any promissory
notes that may be issued by the Company’s sponsor to the Company for working capital purposes, there are no outstanding options,
warrants or other rights to subscribe for, purchase or acquire from the Company any shares of Common Stock or other equity interests
in the Company, or securities convertible into or exchangeable or exercisable for such equity interests. As of the date hereof,
other than the subsidiary created for purposes of the Transaction, the Company has no subsidiaries and does not own, directly or
indirectly, interests or investments (whether equity or debt) in any person, whether incorporated or unincorporated. There are
no stockholder agreements, voting trusts or other agreements or understandings to which the Company is a party or by which it is
bound relating to the voting of any securities of the Company, other than (A) as set forth in the Company’s filings with
the Securities and Exchange Commission (the “Commission”), together with any amendments, restatements or supplements
thereto (the “SEC Documents”) and (B) as contemplated by the Transaction Agreement. Except as disclosed in the
SEC Documents, the Company had no outstanding indebtedness and will not have any outstanding long-term indebtedness as of immediately
prior to the Closing.

 

    8

     

    

 

2.2.11 Assuming
the accuracy of the Subscriber’s representations and warranties set forth in this Subscription Agreement, no registration
under the Securities Act is required for the offer and sale of the Common Stock by the Company to the Subscriber and the Common
Stock is not being offered in a manner involving a public offering under, or in a distribution in violation of, the Securities
Act or any state securities laws.

 

2.2.12 The
Company has timely filed each SEC Document that the Company was required to file with the Commission under the Exchange Act, since
its initial registration with the SEC. As of their respective dates, each of the SEC Documents complied in all material respects
with the requirements of the Securities Act and the Exchange Act, and the rules and regulations of the Commission promulgated thereunder,
and none of the SEC Documents, when filed, contained any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading; provided, that the Company makes no such representation or warranty with respect to any registration
statement or any proxy statement/prospectus to be filed by the Company with respect to the Transaction or any other information
relating to Evolv or any of its affiliates included in any SEC Report or filed as an exhibit thereto. The financial statements
of the Company included in the SEC Documents comply in all material respects with applicable accounting requirements and the rules
and regulations of the Commission with respect thereto as in effect at the time of filing and fairly present in all material respects
the financial position of the Company as of and for the dates thereof and the results of operations and cash flows for the periods
then ended, subject, in the case of unaudited statements, to normal, year-end audit adjustments. As of the date hereof, there are
no material outstanding or unresolved comments in comment letters from the Staff of the Commission with respect to any of the SEC
Documents.

 

2.2.13 Other
than the Other Subscription Agreements, the Transaction Agreement and any other agreement expressly contemplated by the Transaction
Agreement, the Company has not entered into any side letter or similar agreement with any Other Subscriber or any other investor
in connection with such Other Subscriber’s or investor’s investment in the Company. No Other Subscription Agreement
includes terms and conditions that are more economically advantageous in any respect to any such Other Subscriber than the Subscriber
hereunder, and such Other Subscription Agreements have not been and will not be amended or modified in any material respect following
the date of this Subscription Agreement.

 

2.2.14 The
Company is not an “investment company” within the meaning of the Investment Company Act of 1940, as amended.

 

2.2.15 The
Company has not received any written communication from a governmental entity that alleges that the Company is not in compliance
with or is in default or violation of any applicable law, except where such non-compliance, default or violation would not, individually
or in the aggregate, be reasonably expected to have a Material Adverse Effect.

 

    9

     

    

 

2.2.16 Except
for such matters as have not had and would not be reasonably expected to have, individually or in the aggregate, a Material Adverse
Effect, there is no (i) proceeding pending, or, to the knowledge of the Company, threatened against the Company or (ii) judgment,
decree, injunction, ruling or order of any governmental entity or arbitrator outstanding against the Company.

 

2.2.17 Except
for discussions specifically regarding the offer and sale of the Securities, the Company confirms that neither it nor any other
person acting on its behalf has provided Subscriber or its agents or counsel with any information that constitutes or could reasonably
be expected to constitute material, nonpublic information concerning the Company or any of its subsidiaries, other than with respect
to the Transaction and the transactions contemplated by this Subscription Agreement or the Other Subscription Agreements. Except
with respect to the Transaction and the transactions contemplated by this Subscription Agreement and the Other Subscription Agreements,
no event or circumstance has occurred which, under applicable law, rule or regulation, requires public disclosure at or before
the date hereof or announcement by the Company but which has not been so publicly disclosed.

 

2.2.18 There
are no securities or instruments issued by or to which the Company is a party containing anti-dilution or similar provisions that
will be triggered by the issuance of (i) the Acquired Shares or (ii) the Class A Shares to be issued pursuant to any Other Subscription
Agreement, in each case, that have not been or will not be validly waived on or prior to the Closing Date.

 

2.2.19 The
issued and outstanding Class A common stock of the Company is registered pursuant to Section 12(b) of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), and is listed for trading on the Nasdaq Capital Market (“Nasdaq”).
There is no suit, action, proceeding or investigation pending or, to the knowledge of the Company, threatened against the Company
by the Nasdaq or the Commission with respect to any intention by such entity to deregister the Class A common stock or prohibit
or terminate the listing of the Class A common stock on the NYSE. The Company has taken no action that is designed to terminate
the registration of the Class A common Stock under the Exchange Act.

 

2.2.20 No
broker, finder or other financial consultant has acted on behalf of the Company in connection with this Subscription Agreement
or the transactions contemplated hereby in such a way as to create any liability on Subscriber.

 

2.2.21 (i)
Each of the Company, Merger Sub, any of their respective directors and officers and, to the Company’s knowledge, Evolv, any
of Evolv’s directors and officers and any of the Company’s, Merger Sub’s and Evolv’s employees, representatives,
agents and any person acting on its or their behalf has not engaged in any activity or conduct which would violate any applicable
anti-bribery, anti-corruption or anti-money laundering laws, regulations or rules in any applicable jurisdiction (including the
U.S. Foreign Corrupt Practices Act of 1977, as amended), (ii) the Company, Merger Sub and, to the Company’s knowledge, the
Company has instituted and maintains systems, policies and procedures designed to prevent violation of such laws, regulations and
rules and (iii) no action, suit or proceeding by or before any court or governmental or regulatory agency, authority or body or
any arbitrator having jurisdiction over the Company, Merger Sub, or, to the Company’s knowledge, Evolv with respect to such
laws, regulations and rules is pending and, to the Company’s knowledge, no such actions, suits or proceedings are threatened
or contemplated.

 

    10

     

    

 

3. Settlement
Date and Delivery.

 

3.1 Closing.
The closing of the Subscription contemplated hereby (the “Closing”) is contingent upon the substantially concurrent
consummation of the Transaction, as provided for by the Transaction Agreement. The Closing shall occur on the closing date of,
and immediately prior to, the consummation of the Transaction. Upon not less than five (5) business days’ written notice
from (or on behalf of) the Company to Subscriber (the “Closing Notice”) that the Company reasonably expects
all conditions to the closing of the Transaction to be satisfied on a date that is not less than five (5) business days from
the date of the Closing Notice, Subscriber shall deliver to the Company, at least two (2) business day prior to the closing
date specified in the Closing Notice (the “Closing Date”), to be held in escrow until the Closing, the Purchase
Price for the Securities by wire transfer of United States dollars in immediately available funds to the account specified by the
Company in the Closing Notice against delivery by the Company to Subscriber of the Securities in book-entry form (or in certificated
form if indicated by the Subscriber on the Subscriber’s signature page hereto), free and clear of any liens or other restrictions
(other than those arising under the Subscription Agreement or applicable securities laws). In the event the Closing does not occur
within two (2) business days of the Closing Date, the Company shall promptly (but not later than one (1) business day thereafter)
return the Purchase Price to Subscriber. The failure of the Closing to occur on the Closing Date shall not terminate this Subscription
Agreement or otherwise relieve any party of any of its obligations hereunder. For purposes of this Subscription Agreement, “business
day” means any day that, in New York, New York, is neither a legal holiday nor a day on which banking institutions are generally
authorized or required by law or regulation to close.

 

3.2 Conditions
to Closing.

 

3.2.1 The
Closing shall be subject to the satisfaction or valid waiver by the Company, on the one hand, or the Subscriber, on the other,
of the conditions that, on the Closing Date:

 

(i) No
suspension of the qualification of the Securities for offering or sale or trading on Nasdaq shall have occurred.

 

(ii) No
Authority shall have enacted, issued, promulgated, enforced or entered any law, rule, regulation, judgment, decree, executive order
or award (whether temporary preliminary or permanent) which is then in effect and has the effect of making the transactions contemplated
hereby illegal or otherwise prohibiting or enjoining the consummation of the transactions contemplated hereby.

 

(iii) All
conditions precedent to the consummation of the Transaction set forth in the Transaction Agreement, as determined by the parties
to the Transaction Agreement, shall have been satisfied or waived by the party entitled to the benefit thereof (other than those
conditions that, by their nature, may only be satisfied at the consummation of the Transaction, but subject to satisfaction of
such conditions as of the consummation of the Transaction), and the closing of the Transaction shall be substantially concurrent
with the Closing.

 

    11

     

    

 

(iv)Solely
with respect to the Subscriber, (i) the Company shall have performed or complied in all material respects with all agreements and
covenants required by this Subscription Agreement to be performed by the Company and (ii))no amendment, waiver or modification
of the Transaction Agreement shall have occurred that would reasonably be expected to materially and adversely affect the economic
benefits that Subscriber would reasonably expect to receive under this Subscription Agreement, unless Subscriber has previously
consented in writing to such amendment or modification

 

(v) Solely
with respect to the Company, the Subscriber shall have performed or complied in all material respects with all agreements and covenants
required by this Subscription Agreement to be performed by the Subscriber.

 

(vi) Solely
with respect to the Subscriber, all representations and warranties of the Company contained in this Subscription Agreement shall
be true and correct in all material respects as of the Closing Date (other than those representations and warranties expressly
made as of an earlier date, which shall be true and correct in all respects as of such date).

 

(vii) Solely
with respect to the Company, all representations and warranties of the Subscriber contained in this Subscription Agreement shall
be true and correct in all material respects as of the Closing Date (other than those representations and warranties expressly
made as of an earlier date, which shall be true and correct in all respects as of such date).

 

(viii) The
Company shall have filed with NASDAQ an application or supplemental listing application for the listing of the Securities and Nasdaq
shall have raised no objection with respect thereto, subject to official notice of issuance.

 

(ix) Solely
with respect to the Subscriber, there shall have been no amendment, waiver or modification to the Other Subscription Agreements
that materially economically benefits the Other Subscribers thereunder unless the Subscriber has been offered substantially the
same benefits.

 

(x) Solely
with respect to the Subscriber, from and after the date hereof, there shall have not occurred a Material Adverse Effect.

 

    12

     

    

 

4. Transfer
Restrictions.

 

4.1 After
the consummation of the Transaction, the Securities may only be resold, transferred, pledged or otherwise disposed of in compliance
with state and federal securities laws and pursuant to an effective registration statement, Rule 144 under the Securities Act (“Rule
144”) or pursuant to another applicable exemption from the registration requirements of the Securities Act, to the Company
or to an affiliate of the Subscriber. As a condition of transfer (other than pursuant to an effective registration statement pursuant
to Rule 144 or pursuant to another applicable exemption from the registration requirements of the Securities Act), any such transferee
shall agree in writing to be bound by the terms of this Subscription Agreement and shall have the rights and obligations of the
Subscriber under this Agreement.

 

4.2 The
Company acknowledges that the Securities may be pledged by Subscriber in connection with a bona fide margin agreement, provided
that such pledge shall be pursuant to an available exemption from the registration requirements of the Securities Act or pursuant
to, and in accordance with, a registration statement that is effective under the Securities Act at the time of such pledge, and
Subscriber effecting a pledge of the Securities shall not be required to provide the Company with any notice thereof; provided,
however, that neither the Company nor its counsel shall be required to take any action (or refrain from taking any action) in connection
with any such pledge, other than providing any such lender of such margin agreement with an acknowledgment that the Subscribed
Shares are not subject to any contractual lock up or prohibition on pledging, the form of such acknowledgment to be subject to
review and comment by the Company in all respects.

 

4.3 Subject
to applicable requirements of the Securities Act and the interpretations of the Commission thereunder and any requirements of the
Company’s transfer agent, the Company shall use commercially reasonable efforts to ensure that instruments, whether certificated
or uncertificated, evidencing the Securities shall not contain any legend (including the legend set forth in Section 4.4 below)
(i) following any sale of such Securities pursuant to Rule 144, (ii) if such Securities are eligible for sale under Rule 144 without
the requirement for the Company to be in compliance with the current public information required under Rule 144 and without volume
or manner-of-sale restrictions, and in each case, the Subscriber provides the Company with an undertaking to effect any sales or
other transfers in accordance with the Securities Act, or (iii) if such legend is not required under applicable requirements of
the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission).

 

4.4 The
Subscriber agrees to the imprinting, so long as is required by this Section 4, of a legend on any of the Securities
in the following form:

 

THIS SECURITY HAS NOT
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION
FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE
STATE SECURITIES LAWS.

 

    13

     

    

 

4.5
The Subscriber hereby acknowledges and agrees that it will not, and will cause each person acting at the Subscriber’s direction
or pursuant to any understanding with the Subscriber to not, directly or indirectly offer, sell, pledge, contract to sell or sell
any option to purchase, or engage in hedging activities or execute any “short sales” as defined in Rule 200 of Regulation
SHO under the Exchange Act, in each case that result in the Subscriber having a net short cash position in respect of the Securities
until the consummation of the transactions contemplated hereby (or such earlier termination of this Subscription Agreement in accordance
with its terms). For the avoidance of doubt, nothing contained herein shall prohibit Subscriber from engaging in (i) any purchase
of securities by the Subscriber, its controlled affiliates or any person or entity acting on behalf of the Subscriber or any of
its controlled affiliates in an open market transaction after the execution of this Subscription Agreement, or (ii) any sale (including
the exercise of any redemption right) of securities of the Company (A) held by the Subscriber, its controlled affiliates or any
person or entity acting on behalf of the Subscriber or any of its controlled affiliates prior to the execution of this Subscription
Agreement or (B) purchased by the Subscriber, its controlled affiliates or any person or entity acting on behalf of the Subscriber
or any of its controlled affiliates in an open market transaction after the execution of this Subscription Agreement. Notwithstanding
the foregoing, (i) nothing herein shall prohibit other entities under common management with Subscriber that have no knowledge
of this Subscription Agreement or of Subscriber’s participation in the Transaction (including the Subscriber’s controlled
affiliates and/or affiliates) from entering into any “short sales” as defined in Rule 200 of Regulation SHO under the
Exchange Act and (ii) in the case of an Subscriber that is a multi-managed investment vehicle whereby separate portfolio managers
manage separate portions of such Subscriber’s assets and the portfolio managers have no knowledge of the investment decisions
made by the portfolio managers managing other portions of such Subscriber’s assets, the representation set forth above shall
only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Subscription Agreement.

 

4.6 The
Company will use all commercially reasonable efforts to make all Securities DRS eligible so that Subscriber can move shares to
respective prime broker accounts and sell without restriction.

 

5. Termination.
Except for the provisions of Sections 5, 7 and 9 and the indemnification and contribution provisions of Section 6 and the provisions
of this Agreement providing for the return of funds previously delivered in the event the Closing does not occur, all of which
shall survive any termination hereunder, this Subscription Agreement shall terminate and be void and of no further force and effect,
and all rights and obligations of the parties hereunder shall terminate without any further liability on the part of any party
in respect thereof, upon the earlier to occur of (i) such date and time as the Transaction Agreement is terminated in accordance
with its terms, (ii) upon the mutual written agreement of each of the parties hereto and Evolv to terminate this Subscription
Agreement, (iii) if any of the conditions to Closing set forth in Section 3.2 of this Subscription Agreement are not
satisfied or waived by the party entitled to grant such waiver on or prior to the Closing and, as a result thereof, the transactions
contemplated by this Subscription Agreement are not consummated at the Closing or (iv) if the Closing shall not have occurred on
or before the Outside Date (as defined in the Transaction Agreement); provided, that, subject to the limitations set forth
in Section 9, nothing herein will relieve any party from liability for any willful breach hereof prior to the time of termination,
and each party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from such
breach. The Company shall promptly notify Subscriber of the termination of the Transaction Agreement promptly after the termination
of such agreement.

 

    14

     

    

 

6. Registration
Rights.

 

6.1 The
Company agrees that, within thirty (30) calendar days after the consummation of the Transaction (the “Filing Deadline”),
the Company will file with the Commission (at the Company’s sole cost and expense) a registration statement to register under
and in accordance with the provisions of the Securities Act, the resale of all Registrable Securities (as defined below) on Form
S-3 or Form S-1 (which in either case shall be filed pursuant to Rule 415 under the Securities Act as a secondary-only registration
statement), which shall be on Form S-3 if the Company is then eligible for such short form, or any similar or successor short form
registration or, if the Company is not then eligible for such short form registration or would not be able to register for resale
all of the Registrable Securities on Form S-3, on Form S-1 or any similar or successor long form registration (the “Registration
Statement”). The Company will provide a draft of the Registration Statement to the Subscriber for review at least three
(3) business days in advance of the filing the Registration Statement, and shall advise the Subscriber upon the Registration Statement
being declared effective by the Commission. The Company shall use its commercially reasonable efforts to have the Registration
Statement declared effective by the Commission as soon as practicable after the filing thereof, but no later than the earlier of
(i) thirty (30) calendar days following the Filing Deadline (or sixty (60) calendar days if the Commission notifies the Company
that it will “review” the Registration Statement) and (ii) the 5th business day after the date the Company is notified
in writing by the Commission that the Registration Statement will not be “reviewed” or will not be subject to further
review (such earlier date, the “Effectiveness Deadline”); provided, however, that the Company’s obligations
to include the Registrable Securities of a Holder in the Registration Statement are contingent upon such Holder furnishing in writing
to the Company such information regarding such Holder, the securities of the Company held by Holder and the intended method of
disposition of the Registrable Securities as shall be reasonably requested by the Company to effect the registration of the Registrable
Securities, and shall execute such documents in connection with such registration as the Company may reasonably request that are
customary of a selling shareholder in similar situations. Notwithstanding the foregoing, if the Commission prevents the Company
from including any or all of the Common Stock proposed to be registered under the Registration Statement due to limitations on
the use of Rule 415 under the Securities Act for the resale of the Registrable Securities by the Holders or otherwise, the Company
shall use its best efforts to ensure that the Commission determines that (1) the offering contemplated by the Registration Statement
is a bona fide secondary offering and not an offering “by or on behalf of the issuer” as defined in Rule 415 of the
Securities Act and (2) the Subscriber is not a statutory underwriter. If the Company is unsuccessful in the efforts described in
the preceding sentence then (i) the Company shall cause such Registration Statement to register for resale such number of Common
Stock which is equal to the maximum number of Common Stock as is permitted by the Commission and (ii) the Subscriber shall have
an opportunity to withdraw its Registrable Securities. In such event, the number of Common Stock to be registered for each selling
shareholder named in the Registration Statement shall be reduced pro rata among all such selling shareholders. The Company will
use its commercially reasonable efforts to maintain the continuous effectiveness of the Registration Statement until the earliest
of (x) such time as when all such securities cease to be Registrable Securities (as defined below), (y) such time as when all Holders
with Registrable Securities included in such Registration Statement have notified the Company that such Registrable Securities
have actually been sold and (z) two years from the Closing Date. The Company will use its commercially reasonable efforts to cause
the removal of all restrictive legends from any Registrable Securities being sold under the Registration Statement at the time
of sale of such Registrable Securities upon the receipt of such supporting documentation, if any, as requested by the Company.
The Company will use commercially reasonable efforts to file all reports, and provide all customary and reasonable cooperation,
reasonably necessary to enable Holder to resell Registrable Securities pursuant to the Registration Statement, qualify the Registrable
Securities for listing on the applicable stock exchange and update or amend the Registration Statement as necessary to include
Registrable Securities. “Registrable Securities” shall mean, as of any date of determination, the Securities
and any other equity security issued or issuable with respect to the Securities by way of share split, dividend, distribution,
recapitalization, merger, exchange, replacement or similar event, provided, however, that such securities shall cease to be Registrable
Securities at the earliest of (A) four (4) years, (B) the date all Securities held by a Holder may be sold by such Holder without
volume or manner of sale limitations pursuant to Rule 144 and without the requirement for the Company to be in compliance with
the current public information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable), (C) the date on which such securities
have actually been sold by a Holder, or (D) when such securities shall have ceased to be outstanding. “Holder”
shall mean the Subscriber or any affiliate of the Subscriber to which the rights under this Section 6 shall have been assigned.
Notwithstanding the foregoing, the Subscriber shall not be required to sign any form of lock-up agreement. The Subscriber may deliver
written notice (an “Opt-Out Notice”) to the Company requesting that the Subscriber not receive notices from
the Company otherwise required by this Section 6.1; provided, however, that the Subscriber may later revoke any such Opt-Out Notice
in writing. Following receipt of an Opt-Out Notice from the Subscriber (unless subsequently revoked), (i) the Company shall not
deliver any such notices to the Subscriber and the Subscriber shall no longer be entitled to the rights associated with any such
notice and (ii) the Subscriber will notify the Company in writing at least two (2) business days in advance of each intended use
of an effective Registration Statement,, and if a notice of a Suspension Event (as defined below) was previously delivered (or
would have been delivered but for the provisions of this Section 6.1) and the related suspension period remains in effect, the
Company will so notify the Subscriber, within one (1) business day of the Subscriber’s notification to the Company, by delivering
to the Subscriber a copy of such previous notice of Suspension Event, and thereafter will provide the Subscriber with the related
notice of the conclusion of such Suspension Event promptly following its availability.

 

    15

     

    

 

6.2 At
its expense the Company shall:

 

6.2.1 except
for such times as the Company is permitted hereunder to suspend the use of the prospectus forming part of a Registration Statement,
use its commercially reasonable efforts to keep such registration, and any qualification, exemption or compliance under state securities
laws that the Company determines to obtain in connection with such registration, continuously effective with respect to Subscriber,
and to keep the applicable Registration Statement or any subsequent shelf registration statement free of any material misstatements
or omissions, until all securities acquired by Subscriber hereunder cease to be Registrable Securities or such shorter period upon
which Subscriber has notified the Company that such Registrable Securities have actually been sold;

 

6.2.2 advise
Subscriber within two (2) business days: (A) of the issuance by the Commission of any stop order suspending the effectiveness of
any Registration Statement or the initiation of any proceedings for such purpose; (B) of the receipt by the Company of any notification
with respect to the suspension of the qualification of the Registrable Securities included therein for sale in any jurisdiction
or the initiation or threatening of any proceeding for such purpose; and (C) subject to the provisions in this Subscription Agreement,
of the occurrence of any event that requires the making of any changes in any Registration Statement or prospectus included therein
so that, as of such date, the statements therein are not misleading and do not omit to state a material fact required to be stated
therein or necessary to make the statements therein (in the case of a prospectus, in the light of the circumstances under which
they were made) not misleading. Notwithstanding anything to the contrary set forth herein, the Company shall not, when so advising
Subscriber of such events, provide Subscriber with any material, nonpublic information regarding the Company other than to the
extent that providing notice to Subscriber of the occurrence of the events listed in (A) through (C) above constitutes material,
nonpublic information regarding the Company;

 

6.2.3 use
its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of any Registration Statement
as promptly as reasonably practicable;

 

6.2.4 upon
the occurrence of any event contemplated in Section 6.2, except for such times as the Company is permitted hereunder to suspend,
and has suspended, the use of a prospectus forming part of a Registration Statement, as promptly as reasonably practicable, prepare
a post-effective amendment to such Registration Statement or a supplement to the related prospectus, or file any other required
document so that, as thereafter delivered to purchasers of the Registrable Securities included therein, such prospectus will not
include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading;;

 

6.2.5 use
its commercially reasonable efforts to cause all Securities to be listed on each securities exchange or market, if any, on which
the Common Stock issued by the Company have been listed; and

 

6.2.6 use
its commercially reasonable efforts to take all other steps necessary to effect the registration of the Registrable Securities
contemplated hereby.

 

    16

     

    

 

6.3 Notwithstanding
anything to the contrary in this Subscription Agreement, the Company shall be entitled to delay or postpone the effectiveness of
the Registration Statement, and from time to time to require Subscriber not to sell under the Registration Statement or to suspend
the effectiveness thereof, (i) if any information (e.g., compensation data) is not readily available and the non-disclosure of
which in the Registration Statement would be expected, in the reasonable determination of the Company’s board of directors,
upon the advice of external legal counsel, to cause the Registration Statement to fail to comply with applicable disclosure requirements,
(ii) at any time the Company is required to file a post-effective amendment to the Registration Statement and the Commission has
not declared such amendment effective or (iii) if the negotiation or consummation of a transaction by the Company or its subsidiaries
is pending or an event has occurred, which negotiation, consummation or event, the Company’s board of directors reasonably
believes, upon the advice of external legal counsel, would require additional disclosure by the Company in the Registration Statement
of material information that the Company has a bona fide business purpose for keeping confidential and the non-disclosure of which
in the Registration Statement would be expected, in the reasonable determination of the Company’s board of directors, upon
the advice of external legal counsel, to cause the Registration Statement to fail to comply with applicable disclosure requirements
(each such circumstance, a “Suspension Event”); provided, however, the Company shall not so delay filing or
so suspend the use of the Registration Statement on more than two (2) occasions or for a period of more than forty-five (45) consecutive
days or more than a total of one hundred-twenty (120) calendar days, in each case in any three hundred sixty (360) day period.
Upon receipt of any written notice from the Company of the happening of any Suspension Event (which notice shall not contain material
non-public information) during the period that the Registration Statement is effective or if as a result of a Suspension Event
the Registration Statement or related prospectus contains any untrue statement of a material fact or omits to state any material
fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they
were made (in the case of the prospectus) not misleading, Subscriber agrees that (i) it will immediately discontinue offers and
sales of the Registrable Securities under the Registration Statement (excluding, for the avoidance of doubt, sales conducted pursuant
to Rule 144) until such Subscriber receives copies of a supplemental or amended prospectus (which the Company agrees to promptly
prepare) that corrects the misstatement(s) or omission(s) referred to above and receives notice that any post-effective amendment
has become effective or unless otherwise notified by the Company that it may resume such offers and sales, and (ii) it will maintain
the confidentiality of any information included in such written notice delivered by the Company unless otherwise required by law
or subpoena. If so directed by the Company, Subscriber will deliver to the Company or, in such Subscriber’s sole discretion
destroy, all copies of the prospectus covering the Registrable Securities in such Subscriber’s possession; provided, however,
that this obligation to deliver or destroy all copies of the prospectus covering the Registrable Securities shall not apply (i)
to the extent such Subscriber is required to retain a copy of such prospectus (a) in order to comply with applicable legal, regulatory,
self-regulatory or professional requirements or (b) in accordance with a bona fide pre-existing document retention policy or (ii)
to copies stored electronically on archival servers as a result of automatic data back-up.

 

6.4 The
Company shall, notwithstanding any termination of this Subscription Agreement, indemnify, defend and hold harmless Subscriber (to
the extent a seller under the Registration Statement) and any other Holder, and any of their respective officers, directors, agents,
partners, members, stockholders, affiliates, managers, investment advisers and employees, and each person who controls Subscriber
(within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act), to the fullest extent permitted by
applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable
external attorneys’ fees and expenses incurred in connection with defending or investigating any such action or claim) and
expenses (collectively, “Losses”), as incurred, that arise out of or are based upon (i) any untrue or alleged
untrue statement of a material fact contained in the Registration Statement, any prospectus included in the Registration Statement
or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating
to any omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements
therein (in the case of any prospectus or form of prospectus or supplement thereto, in the light of the circumstances under which
they were made) not misleading or (ii) any violation or alleged violation by the Company of the Securities Act, Exchange Act or
any state securities law or any rule or regulation thereunder, in connection with the performance of its obligations under this
Section 6, except insofar as and to the extent, but only to the extent, that such untrue statements, alleged untrue statements,
omissions or alleged omissions are based upon information regarding the Subscriber furnished in writing to the Company by such
Subscriber expressly for use therein or such Subscriber has omitted a material fact from such information or otherwise violated
the Securities Act, the Exchange Act or any state securities law or any rule or regulation thereunder; provided, however, that
the indemnification contained in this Section 6 shall not apply to amounts paid in settlement of any Losses if such settlement
is effected without the consent of the Company (which consent shall not be unreasonably withheld, conditioned or delayed), nor
shall the Company be liable for any Losses to the extent they arise out of or are based upon a violation which occurs (A) in reliance
upon and in conformity with written information furnished by such Subscriber, (B) in connection with any failure of such person
to deliver or cause to be delivered a prospectus made available by the Company in a timely manner, (C) as a result of offers or
sales effected by or on behalf of any person by means of a “free writing prospectus” (as defined in Rule 405 under
the Securities Act) that was not authorized in writing by the Company, or (D) in connection with any offers or sales effected by
or on behalf of such Subscriber in violation of Section 6.3 hereof. The Company shall notify the Subscriber and each other Holder
promptly of the institution, threat or assertion of any proceeding arising from or in connection with the transactions contemplated
by this Section 6 of which the Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of an indemnified party and shall survive the transfer of the Securities by Subscriber or any other Holder.

 

    17

     

    

 

6.5 Subscriber
or any Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents and employees,
and each person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange
Act), to the fullest extent permitted by applicable law, from and against all Losses, as incurred, arising out of or are based
upon any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any prospectus included
in the Registration Statement, or any form of prospectus, or in any amendment or supplement thereto or in any preliminary prospectus,
or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein (in the case of any prospectus, or any form of prospectus or supplement thereto, in light of the
circumstances under which they were made) not misleading to the extent, but only to the extent, that such untrue statements or
omissions are based solely upon information regarding such Subscriber or Holder furnished to the Company by such Subscriber or
such Holder expressly for use therein; provided, however, that the indemnification contained in this Section 6 shall not apply
to amounts paid in settlement of any Losses if such settlement is effected without the consent of such Subscriber (which consent
shall not be unreasonably withheld, conditioned or delayed). In no event shall the liability of such Subscriber or such Holder
be greater in amount than the dollar amount of the net proceeds received by such Subscriber or such Holder upon the sale of the
Securities giving rise to such indemnification obligation. Subscriber shall notify the Company promptly of the institution, threat
or assertion of any proceeding arising from or in connection with the transactions contemplated by this Section 6 of which such
Subscriber is aware, provided that a failure by Subscriber to provide such notice shall not impact Subscriber’s right to
be indemnified hereunder unless Company is actually prejudiced thereby. Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of an indemnified party and shall survive the transfer of the Securities by Subscriber
or any other Holder.

 

6.6 If
the indemnification provided under this Section 6 from the indemnifying party is unavailable or insufficient to hold harmless an
indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying
party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as
a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative
fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative
fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action
in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material
fact, was made by, or relates to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s
and indemnified party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action.
The amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include,
subject to the limitations set forth in this Section 6, any legal or other fees, charges or expenses reasonably incurred by such
party in connection with any investigation or proceeding. No person guilty of fraudulent misrepresentation (within the meaning
of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this Section 6 from any person who was not
guilty of such fraudulent misrepresentation. Each indemnifying party’s obligation to make a contribution pursuant to this
Section 6.7 shall be individual, not joint and several, and in no event shall the liability of Subscriber or Holder hereunder be
greater in amount than the dollar amount of the net proceeds received by such Subscriber or such Holder upon the sale of the Securities
giving rise to such indemnification obligation.

 

7. Miscellaneous.

 

7.1 Further
Assurances. At the Closing, the parties hereto shall execute and deliver such additional documents and take such additional
actions as the parties reasonably may deem to be practical and necessary in order to consummate the Subscription as contemplated
by this Subscription Agreement.

 

    18

     

    

 

7.1.1 Subscriber
acknowledges that the Company, the Placement Agents and others will rely on the acknowledgments, understandings, agreements, representations
and warranties contained in this Subscription Agreement. Prior to the Closing, Subscriber agrees to promptly notify the Company
if any of the acknowledgments, understandings, agreements, representations and warranties made by the Subscriber set forth herein
are no longer accurate in all material respects. Subscriber further acknowledges and agrees that the Placement Agents are third-party
beneficiaries of the representations and warranties of the Subscriber contained in Section 2.1 of this Subscription Agreement.

 

7.1.2 Each
of the Company and the Subscriber is entitled to rely upon this Subscription Agreement and is irrevocably authorized to produce
this Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry
with respect to the matters covered hereby, in each case, to the extent required by applicable law.

 

7.1.3 The
Company may request from Subscriber such additional information as the Company may deem reasonably necessary to evaluate the eligibility
of Subscriber to acquire the Securities, and Subscriber shall use reasonable best efforts to promptly provide such information
as may be reasonably requested, to the extent readily available and to the extent consistent with its internal policies and procedures,
provided that the Company agrees to keep confidential any such information provided by Subscriber.

 

7.2 Notices.
Any notice or communication required or permitted hereunder shall be in writing and either delivered personally, emailed or sent
by overnight mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, and shall be deemed
to be given and received (i) when so delivered personally, (ii) when sent, with confirmation of receipt, if sent by email,
or (iii) three (3) business days after the date of mailing to the address below or to such other address or addresses as such
person may hereafter designate by notice given hereunder:

 

(i) if
to Subscriber, to such address or addresses set forth on the signature page hereto;

 

(ii) if
to the Company (prior to the Closing), to:

 

NewHold Investment
Corp.

52 Vanderbilt Avenue, Suite 2005

New York, NY 10017

Attention: Kevin Charlton

Email: kcharlton@newholdllc.com

 

with a required copy to (which copy shall not constitute
notice):

 

Loeb & Loeb LLP

345 Park Avenue, 19th Floor

New York, NY 10154

Attention: Lloyd L. Rothenberg, Esq.

E-mail: lrothenberg@loeb.com

 

    19

     

    

 

(iii) if
to the Company (following the Closing) to:

 

Evolv Technologies,
Inc.

200 West Street, Third Floor

Waltham, MA 02451

Attn: Eric Pyenson

Email: epyenson@evolvtechnology.com

 

with a required copy to (which copy shall
not constitute notice):

 

Latham & Watkins
LLP

200 Clarendon Street

Boston, MA 02116

Attn: Ryan J. Maierson; Stephen W. Ranere; Daniel S. Hoffman

Email: Ryan.Maierson@lw.com; Stephen.Ranere@lw.com; Daniel.Hoffman@lw.com

 

7.3 Entire
Agreement. This Subscription Agreement constitutes the entire agreement, and supersedes all other prior agreements, understandings,
representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof. Except as
otherwise expressly set forth herein, this Subscription Agreement shall not confer rights or remedies upon any person other than
the parties hereto and their respective successors and assigns.

 

7.4 Modifications
and Amendments. This Subscription Agreement may not be modified, waived or terminated except by an instrument in writing, signed
by the Company, Evolv and the Subscriber.

 

7.5 Waivers
and Consents. The terms and provisions of this Subscription Agreement may be waived, or consent for the departure therefrom
granted, only by a written document executed by the party against whom enforcement of such waiver or consent is sought. No such
waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of
this Subscription Agreement, whether or not similar. Each such waiver or consent shall be effective only in the specific instance
and for the purpose for which it was given, and shall not constitute a continuing waiver or consent.

 

7.6 Assignment.
Neither this Subscription Agreement nor any rights, interests or obligations that may accrue to the parties hereunder (other than
the Securities acquired hereunder, if any and Subscriber’s rights under Section 6 above) may be transferred or assigned without
the prior written consent of the Company; provided, however, Subscriber may transfer or assign its rights, interests
and obligations hereunder to a controlled affiliate of the Subscriber or another investment fund or account managed or advised
by the same manager as Subscriber (or a related party or affiliate), provided, further, that no such transfer or assignment
without the consent of the assigning party shall release Subscriber of its obligations hereunder and such transferee(s) or assignee(s),
as applicable, agrees in writing to be bound by the terms hereof.

 

7.7 Benefit.

 

7.7.1 Except
as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto
and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations,
warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors,
administrators, successors, legal representatives and permitted assigns. Except as expressly provided for herein, this Subscription
Agreement shall not confer rights or remedies upon any person other than the parties hereto and their respective successors and
assigns.

 

    20

     

    

 

7.7.2 Subscriber
acknowledges and agrees that (a) this Subscription Agreement is being entered into in order to induce Evolv to execute and deliver
the Transaction Agreement and without the representations, warranties, covenants and agreements of Subscriber hereunder, the Evolv
would not enter into the Transaction Agreement, (b) each representation, warranty, covenant and agreement of Subscriber hereunder
is being made also for the benefit of the Evolv and the Placement Agents, and (c) Evolv may directly enforce (including by an action
for specific performance, injunctive relief or other equitable relief) each of the covenants and agreements of Subscriber under
this Subscription Agreement.

 

7.7.3 Each
of the parties agrees that Evolv is a party to the Transaction Agreement is a third party beneficiary of this Agreement and Evolv
may directly enforce (including by an action for specific performance, injunctive relief or other equitable relief) each of the
covenants and agreements of Subscriber under this Agreement, as amended, modified, supplemented or waived in accordance with Section
7.4. Each of the parties further agrees that each Placement Agent is a third-party beneficiary of the representations and warranties
of Subscriber and the Company under this Subscription Agreement.

 

7.8 Governing
Law. This Subscription Agreement, and any claim or cause of action hereunder based upon, arising out of or related to this
Subscription Agreement (whether based on law, in equity, in contract, in tort or any other theory) or the negotiation, execution,
performance or enforcement of this Subscription Agreement, shall be governed by and construed in accordance with the laws of the
State of New York, without giving effect to the principles of conflicts of law thereof.

 

7.9 Consent
to Jurisdiction; Waiver of Jury Trial. The parties hereto agree to submit any matter or dispute resulting from or arising out
of the execution, performance, interpretation, breach or termination of this Agreement to the non-exclusive jurisdiction of federal
or state courts within the State of New York. Each of the parties agrees that service of any process, summons, notice or document
in the manner set forth in Section 7.2 hereof or in such other manner as may be permitted by applicable law, shall be effective
service of process for any proceeding in the State of New York with respect to any matters to which it has submitted to jurisdiction
in this Section 7.9. Each of the parties hereto irrevocably and unconditionally agrees that it is subject to, and hereby submits
to, the personal jurisdiction of the courts located in the State of New York for any action, suit or proceeding arising out of
this Subscription Agreement or the transactions contemplated hereunder and waives any objection to the laying of venue in the United
States District Court for the Southern District of New York, or the New York state courts if the federal jurisdictional standards
are not satisfied, and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court
that any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum. TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW, EACH OF THE PARTIES HEREBY IRREVOCABLY WAIVES ITS RIGHTS TO A TRIAL BY JURY.

 

    21

     

    

 

8. Non-Reliance
and Exculpation. The Subscriber acknowledges that it is not relying upon, and has not relied upon, any statement, representation
or warranty made by any person, firm or corporation (including, without limitation, the Placement
Agents, any of their respective affiliates or any of its or their control persons, officers, directors, employees, partners,
agents, and any representatives of any of the foregoing), other than the statements, representations and warranties of the Company
expressly contained in Section 2.2 of this Subscription Agreement, in making its investment or decision to invest in the Company.
The Subscriber acknowledges and agrees that neither of the Placement Agents, nor their respective
affiliates or any of its or their respective control persons, officers, directors, employees or representatives shall have
any liability to the Subscriber pursuant to, arising out of or relating to this Subscription Agreement,
the negotiation hereof or its subject matter, or the transactions contemplated hereby, including, without limitation, with
respect to any action heretofore or hereafter taken or omitted to be taken by any of them
in connection with the purchase of the Securities or with respect to any claim (whether in tort, contract or otherwise)
for breach of this Subscription Agreement or in respect of any written or oral representations made or alleged to be made in connection
herewith, as expressly provided herein, or for any actual or alleged inaccuracies, misstatements or omissions with respect to any
information or materials of any kind furnished by the Company the Placement Agents or any other person or entity concerning the
Company. the Placement Agents, any of their respective controlled affiliates, this Subscription Agreement or the transactions contemplated
hereby.

 

8.1 Severability.
If any provision of this Subscription Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability
of the remaining provisions of this Subscription Agreement shall not in any way be affected or impaired thereby and shall continue
in full force and effect.

 

8.2 No
Waiver of Rights, Powers and Remedies. No failure or delay by a party hereto in exercising any right, power or remedy under
this Subscription Agreement, and no course of dealing between the parties hereto, shall operate as a waiver of any such right,
power or remedy of such party. No single or partial exercise of any right, power or remedy under this Subscription Agreement by
a party hereto, nor any abandonment or discontinuance of steps to enforce any such right, power or remedy, shall preclude such
party from any other or further exercise thereof or the exercise of any other right, power or remedy hereunder. The election of
any remedy by a party hereto shall not constitute a waiver of the right of such party to pursue other available remedies. No notice
to or demand on a party not expressly required under this Subscription Agreement shall entitle the party receiving such notice
or demand to any other or further notice or demand in similar or other circumstances or constitute a waiver of the rights of the
party giving such notice or demand to any other or further action in any circumstances without such notice or demand.

 

8.3 Survival
of Representations and Warranties. All representations and warranties made by the parties hereto in this Subscription Agreement
or in any other agreement, certificate or instrument provided for or contemplated hereby, shall survive the Closing until the expiration
of any statute of limitations under applicable law.

 

    22

     

    

 

8.4 Expenses.
Except for placement fees equal to 3% of gross proceeds payable to the Placement Agents, each of Evolv and the Company has not
paid, and is not obligated to pay, any brokerage, finder’s or other fee or commission in connection with its issuance and
sale of the Securities, including, for the avoidance of doubt, any fee or commission payable to any stockholder or affiliate of
the Company.

 

8.5 Headings
and Captions. The headings and captions of the various subdivisions of this Subscription Agreement are for convenience of reference
only and shall in no way modify or affect the meaning or construction of any of the terms or provisions hereof.

 

8.6 Counterparts.
This Subscription Agreement may be executed in one or more counterparts (including by facsimile or electronic mail or in .pdf),
all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have
been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart.
In the event that any signature is delivered by facsimile transmission or any other form of electronic delivery, such signature
shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same
force and effect as if such signature page were an original thereof.

 

8.7 Construction.
The words “include,” “includes,” and “including” will be deemed to be
followed by “without limitation.” Pronouns in masculine, feminine, and neuter genders will be construed to include
any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise
requires. The words “this Subscription Agreement,” “herein,” “hereof,”
“hereby,” “hereunder,” and words of similar import refer to this Subscription Agreement as
a whole and not to any particular subdivision unless expressly so limited. The parties hereto intend that each representation,
warranty, and covenant contained herein will have independent significance. If any party hereto has breached any representation,
warranty, or covenant contained herein in any respect, the fact that there exists another representation, warranty or covenant
relating to the same subject matter (regardless of the relative levels of specificity) which such party hereto has not breached
will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty, or covenant.
All references in this Subscription Agreement to numbers of shares, per share amounts and purchase prices shall be appropriately
adjusted to reflect any stock split, stock dividend, stock combination, recapitalization or the like occurring after the date hereof.

 

8.8 Mutual
Drafting. This Subscription Agreement is the joint product of Subscriber and the Company and each provision hereof has been
subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party
hereto.

 

    23

     

    

 

8.9 Remedies.

 

8.9.1 The
parties agree that the irreparable damage would occur if this Subscription Agreement was not performed in accordance with its specific
terms or was otherwise breached and that money damages or other legal remedies would not be an adequate remedy for any such damage.
It is accordingly agreed that the parties hereto shall be entitled to equitable relief, including in the form of an injunction
or injunctions, to prevent breaches or threatened breaches of this Subscription Agreement and to enforce specifically the terms
and provisions of this Subscription Agreement in an appropriate court of competent jurisdiction as set forth in Section 7.8, this
being in addition to any other remedy to which any party is entitled at law or in equity, including money damages. The right to
specific enforcement shall include the right of the parties hereto to cause to cause the other parties hereto to cause the transactions
contemplated hereby to be consummated on the terms and subject to the conditions and limitations set forth in this Subscription
Agreement. The parties hereto further agree (i) to waive any requirement for the security or posting of any bond in connection
with any such equitable remedy, (ii) not to assert that a remedy of specific enforcement pursuant to this Section 7.18 is unenforceable,
invalid, contrary to applicable law or inequitable for any reason and (iii) to waive any defenses in any action for specific performance,
including the defense that a remedy at law would be adequate.

  

8.9.2 The
parties acknowledge and agree that this Section 7.18 is an integral part of the transactions contemplated hereby and without that
right, the parties hereto would not have entered into this Subscription Agreement.

 

8.9.3 In
any dispute arising out of or related to this Subscription Agreement, or any other agreement, document, instrument or certificate
contemplated hereby, or any transactions contemplated hereby or thereby, the applicable adjudicating body shall award to the prevailing
party, if any, the documented and out-of-pocket costs and external attorneys’ fees reasonably incurred by the prevailing
party in connection with the dispute and the enforcement of its rights under this Subscription Agreement or any other agreement,
document, instrument or certificate contemplated hereby and, if the adjudicating body determines a party to be the prevailing party
under circumstances where the prevailing party won on some but not all of the claims and counterclaims, the adjudicating body may
award the prevailing party an appropriate percentage of the documented out-of-pocket costs and external attorneys’ fees reasonably
incurred by the prevailing party in connection with the adjudication and the enforcement of its rights under this Subscription
Agreement or any other agreement, document, instrument or certificate contemplated hereby or thereby.

 

9. Disclosure.

 

9.1 The
Company shall, by 9:00 a.m., New York City time, on the first (1st) business day immediately following the date of this
Subscription Agreement file a Current Report on Form 8-K or press release filed with the Commission (the time of such filing, “Disclosure
Time”) and a form of this Subscription Agreement will be filed with the Commission as an exhibit thereto. From and after
the Disclosure Time, the Company represents to the Subscriber that it shall have publicly disclosed all material, non-public information
delivered to the Subscriber by the Company, Evolv or any of their officers, directors, employees or agents in connection with the
transactions contemplated by the Subscription Agreement and the Transaction Agreement, and the Subscriber shall no longer be subject
to any confidentiality or similar obligations under any current agreement, whether written or oral with Company, Placement Agents
or any of their affiliates, relating to the transactions contemplated by this Subscription Agreement.

 

    24

     

    

 

9.2 Subscriber
hereby consents to the publication and disclosure in (x) any Form 8-K filed by the Company with the Commission in connection with
the execution and delivery of the Merger Agreement, the definitive agreement relating to the Transaction and any filing with the
Commission made in connection therewith, including any proxy statement, prospectus or registration statement related thereto or
any other filing with the Commission pursuant to applicable securities laws, and (y) any other documents or communications, including
press-releases, provided by the Company in connection with the execution and delivery of the Merger Agreement or the definitive
agreement relating to the Transaction, the nature of Subscriber’s commitments, arrangements and understandings under and
relating to this Subscription Agreement and, if deemed required or appropriate by the Company, a copy of this Subscription Agreement
but in each case solely to the extent disclosure is required by law, at the request of the Commission or regulatory agency.

 

10. Trust
Account Waiver. Subscriber acknowledges that the Company is a blank check company with the powers and privileges to effect
a merger, asset acquisition, reorganization or similar business combination involving the Company and one or more businesses or
assets. Subscriber further acknowledges that, as described in the Company’s prospectus relating to its initial public offering
dated July 30, 2020 (the “Prospectus”) available at www.sec.gov, substantially all of the Company’s assets
consist of the cash proceeds of Company’s initial public offering and private placements of its securities, and substantially
all of those proceeds have been deposited in a trust account (the “Trust Account”) for the benefit of Company,
its public shareholders and the underwriters of Company’s initial public offering. Except with respect to interest earned
on the funds held in the Trust Account that may be released to Company to pay its tax obligations, if any, the cash in the Trust
Account may be disbursed only for the purposes set forth in the Prospectus. For and in consideration of the Company entering into
this Subscription Agreement, the receipt and sufficiency of which are hereby acknowledged, Subscriber, on behalf of itself and
its representatives, hereby irrevocably waives any and all right, title and interest, or any claim of any kind they have or may
have in the future, in or to any monies held in the Trust Account, and agrees not to seek recourse against the Trust Account as
a result of, or arising out of, this Subscription Agreement; provided, however, that nothing in this Section 9 (x) shall
serve to limit or prohibit the Subscriber’s right to pursue a claim against Company for legal relief against assets held
outside the Trust Account, for specific performance or other equitable relief, (y) shall serve to limit or prohibit any claims
that the Subscriber may have in the future against Company’s assets or funds that are not held in the Trust Account (including
any funds that have been released from the Trust Account and any assets that have been purchased or acquired with any such funds)
or (z) shall be deemed to limit any Subscriber’s right, title, interest or claim to the Trust Account by virtue of such
Subscriber’s record or beneficial ownership of securities of the Company acquired by any means other than pursuant to this
Subscription Agreement, including but not limited to any redemption right with respect to any such securities of the Company.

 

[Signature Page Follows]

 

    25

     

    

 

IN WITNESS WHEREOF,
each of the Company and Subscriber has executed or caused this Subscription Agreement to be executed by its duly authorized representative
as of the date set forth below.

 

	 	NEWHOLD INVESTMENT CORP.
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 	 

 

Accepted and agreed this __th
day of [____], 2021.

 

SUBSCRIBER:

 

	Signature of Subscriber:	 	Signature of Joint Subscriber, if applicable:
	 	 	 	 	 
	By:	 	 	By:	 
	 	Name:	 	 	Name:
	 	Title:	 	 	Title:

 

Date: [●], 2021

 

	Name of Subscriber:	 	Name of Joint Subscriber, if applicable
	 	 	 
	 	 	 
	(Please print. Please indicate name and	 	(Please print. Please indicate name and
	capacity of person signing above)	 	capacity of per son signing above)

 

	 	 	 	 	 	 	 
	

        Name in which securities are to be registered (if different
        from the name of Subscriber listed directly above):
	 	 	 	 	 	 
	 	 	 	 
	Email Address:	 	 	 	 	 	 
	 	 	 	 
	If there are joint investors, please check one:	 	 	 	 	 	 
	 	 	 	 
	☐   Joint Tenants with Rights of Survivorship	 	 	 	 	 	 
	 	 	 	 
	☐   Tenants-in-Common	 	 	 	 	 	 
	 	 	 	 
	☐   Community Property	 	 	 	 	 	 
	 	 	 
	Subscriber’s EIN: __________________________	 	 	 	Joint Subscriber’s EIN: ________________
	 	 	 
	Business Address-Street:	 	 	 	Mailing Address-Street (if different):
	 	 	 	 
	 	 	 	 
		 	 
	

        City, State, Zip:
	 	 	 	

        City, State, Zip:

 

    26

     

    

 

	Attn:	 	Attn:
	 	 
	Telephone No.: __________________________	 	Telephone No.: _____________________
	 	 
	Facsimile No.: __________________________	 	Facsimile No.: ______________________
	 	 
	
        Aggregate Number of shares of Common Stock subscribed for:

        
	 	 
	 
	
        Aggregate Purchase Price: $

        

 

You must pay the Purchase Price by wire
transfer of U.S. dollars in immediately available funds to the account specified by the Company in the Closing Notice.

 

If Subscriber wants certificated Securities
rather than book-entry form, indicate here: _____

 

    27

     

    

 

SCHEDULE A

ELIGIBILITY REPRESENTATIONS OF SUBSCRIBER

 

		A.	QUALIFIED INSTITUTIONAL BUYER STATUS

 

(Please check the applicable subparagraphs):

 

		1.	☐We are a “qualified
institutional buyer” (as defined in Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”)
(a “QIB”)).

 

		2.	☐We are subscribing for
the Securities as a fiduciary or agent for one or more investor accounts, and each owner of such account is a QIB.

 

*** OR ***

 

		B.	INSTITUTIONAL ACCREDITED INVESTOR STATUS

 

(Pleasecheck the applicable subparagraphs):

 

		1.	☐We are an “accredited
investor” (within the meaning of Rule 501(a) under the Securities Act) or an entity in which all of the equity holders are
accredited investors within the meaning of Rule 501(a) under the Securities Act, and have marked and initialed the appropriate
box on the following page indicating the provision under which we qualify as an “accredited investor.”

 

		2.	☐We are not a natural
person.

 

*** AND ***

 

		C.	AFFILIATE STATUS

 

(Please check the applicable box) SUBSCRIBER:

 

☐is:

☐is not

 

an “affiliate” (as defined in Rule 144
under the Securities Act) of the Company or acting on behalf of an affiliate of the Company.

 

This page should be completed by
Subscriber

and constitutes a part of the Subscription Agreement.

 

Rule 501(a), in relevant part, states that
an “accredited investor” shall mean any person who comes within any of the below listed categories, or who the issuer
reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person.
Subscriber has indicated, by marking and initialing the appropriate box below, the provision(s) below which apply to Subscriber
and under which Subscriber accordingly qualifies as an “accredited investor.”

 

    Sch. A-1

     

    

 

		☐	Any bank, registered broker or dealer, insurance company, registered investment company, business
development company, or small business investment company; any plan established and maintained by a state, its political subdivisions,
or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has total
assets in excess of $5,000,000; any employee benefit plan within the meaning of the Employee Retirement Income Security Act of
1974 if the investment decision is made by a plan fiduciary, which is either a bank, savings and loan association, insurance company,
or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed
plan, with investment decisions made solely by persons that are accredited investors;

 

		☐	Any private business development company as defined in Section 202(a)(22) of the Investment
Advisers Act of 1940;

 

		☐	Any Small Business Investment Company licensed by the U.S. Small Business Administration under
section 301(c) or (d) of the Small Business Investment Act of 1958, as amended;

 

		☐	Any organization described in Section 501(c)(3) of the Internal Revenue Code, corporation,
Massachusetts or similar business trust, or partnership, not formed for the specific purpose of acquiring the securities offered,
with total assets in excess of $5,000,000;

 

		☐	Any director, executive officer, or general partner of the issuer of the securities being offered
or sold, or any director, executive officer, or general partner of a general partner of that issuer;

 

		☐	Any natural person whose individual net worth, or joint net worth with that person’s spouse,
exceeds $1,000,000. For purposes of calculating a natural person’s net worth: (i) the person’s primary residence
shall not be included as an asset; (ii) indebtedness that is secured by the person’s primary residence, up to the estimated
fair market value of the primary residence at the time of the sale of securities, shall not be included as a liability (except
that if the amount of such indebtedness outstanding at the time of sale of securities exceeds the amount outstanding 60 days before
such time, other than as a result of the acquisition of the primary residence, the amount of such excess shall be included as a
liability); and (iii) indebtedness that is secured by the person’s primary residence in excess of the estimated fair
market value of the primary residence at the time of the sale of securities shall be included as a liability;

 

		☐	Any natural person who had an individual income in excess of $200,000 in each of the two most recent
years or joint income with that person’s spouse in excess of $300,000 in each of those years and has a reasonable expectation
of reaching the same income level in the current year;

 

		☐	Any trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring
the securities offered, whose purchase is directed by a sophisticated person; or

 

		☐	Any entity in which all of the equity owners are accredited investors meeting one or more of the
above tests.

 

 

Sch.
A-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00323-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00323-of-00352.parquet"}]]